Market Research Future

HIV Vaccines Market 2017 -Perceives Enormous Accruals with a Staggering CAGR of 5.0% by 2027; Asserts MRFR


Pune, India -- (SBWIRE) -- 10/13/2017 -- Executive Summary:

Market Research Future published new report, titled "HIV Vaccines Market -Research Report: Global Forecast to 2027".

Market Synopsis of Global HIV Vaccines Market

The globally market for HIV vaccine is one of the fastest growing markets. Although there is no commercial HIV vaccine available in the market; there is huge funding for the research & development of HIV vaccine. The growth of the market is likely to driven by rising R&D funding for HIV vaccine, rising prevalence of HIV due to prostitution, increasing awareness due to HIV prevention programs, growing number of new entrants in the market. Globally the market for HIV vaccine is expected to grow at the rate of about 5.0% from 2016 to 2027.

HIV Vaccine Market has been segmented on the basis of type which comprises of acute paronychia, chronic paronychia, candidal paronychia and pyogenic paronychia. On the basis of antibiotics, market is segmented into mupirocin ointment, fusidic acid ointment, gentamicin ointment, dicloxacillin and others.

Key Players:

Some of the key players in this market are: Argos Therapeutics, Inc, Bionor Pharma Asa, Janssen Global Services, Llc, Genecure Llc, Geovax, Genvec, Inc, Paxvax Corporation, Inovio Pharmaceuticals, Inc, Glaxosmithkline Plc, Sanofi and others


Key Finding

The HIV Vaccine Global Market is expected to reach $ 2,702.3 Billion by 2027.

At end of 2015, US$ 19 billion was invested into the AIDS response in low-and middle-income nations

North America holds the largest market share of 44.4% of HIV vaccine's and is expected to reach $ 1,230.1 billion by the end of forecast period.

North America is expected to be the fastest growing market at a CAGR of 5.2% due to high investment in HIV vaccine R&D.

Regional Analysis:

Globally North America is the largest market for HIV vaccine market. The large size of the market can be attributed to higher adoption of various HIV vaccine trials coupled with presence of technologically and advancement. Europe is the second-largest market for HIV vaccine which is expected to grow at a CAGR of 5.1%. Asia-Pacific HIV market is expected to grow with a steady pace.

Study Objectives:

To provide detailed analysis of the market structure along with forecast for the next 7 years of the various segments and sub-segments of the HIV vaccine market

To provide insights about factors affecting the market growth

To analyze the market based on various factors- price analysis, supply chain analysis, porters five force analysis etc.

To provide forecast revenue of the market segments and sub-segments with respect to the main geography and various regions globally.

To provide regional level analysis of the market with respect to the current market size and future prospective

To provide regional level analysis of the market for segments by clinical trials, and its sub-segments.

To provide overview of key players and their strategic profiling in the market, comprehensively analyzing their core competencies, and drawing a competitive landscape for the market

To track and analyze competitive developments such as joint ventures, strategic alliances, mergers and acquisitions, new product developments, and research and developments in the global HIV vaccine market.

Intended Audience:

Pharmaceutical manufacturers & Suppliers
HIV vaccine products manufacturers & Suppliers
Pharmaceutical and biotechnology companies
Hospitals and diagnostic centers
National Organizations & Government Organizations
Academic research institutes
Government institutes
Market Assessment:

The report for HIV Vaccine Market of Market Research Future comprises of extensive primary research along with the detailed analysis of qualitative as well as quantitative aspects by various industry experts, key opinion leaders to gain the deeper insight of the market and industry performance. The report gives the clear picture of current market scenario which includes historical and projected market size in terms of value and volume, technological advancement, macro economical and governing factors in the market. The report provides details information and strategies of the top key players in the industry. The report also gives a broad study of the different markets segments and regions.

Table of Contents

1 Report Prologue

2 Introduction

3 Research Methodology

4 Market Dynamics

5 Market Factor Analysis

6 Global HIV Vaccine Market, By Clinical Trials

7 Global HIV Vaccine Market, By Region

8 Competitive Landscape

9 Company Profile

10 Appendix

About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Akash Anand,
Market Research Future
+1 646 845 9312